Nu Skin Enterprises (NUS) Reports In-Line Q3 EPS
Get Alerts NUS Hot Sheet
Price: $4.88 +0.62%
EPS Growth %: -5.9%
Financial Fact:
General and administrative expenses: 140.65M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: -5.9%
Financial Fact:
General and administrative expenses: 140.65M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Nu Skin Enterprises (NYSE: NUS) reported Q3 EPS of $0.97, in-line with the analyst estimate of $0.97. Revenue for the quarter came in at $641.2 million versus the consensus estimate of $683.1 million.
GUIDANCE:
Nu Skin Enterprises sees Q4 2021 EPS of $0.90-$1.00, versus the consensus of $0.96. Nu Skin Enterprises sees Q4 2021 revenue of $645-675 million, versus the consensus of $631.9 million.
For earnings history and earnings-related data on Nu Skin Enterprises (NUS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Oracle (ORCL) Tops Q1 EPS by 19c, Beats on Revenue; Beats on Cloud Revenue, Offers Q3 EPS Guidance
- Macy's (M) Tops Q2 EPS by 28c, Beats on Revenue; Offers FY Guidance
- IBEX Limited (IBEX) Tops Q4 EPS by 6c; offers guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share